🚀 WHAT A WEEK! ORTHOWORLD Inc. names ABANZA one of the three “Orthopedic Startups to Watch in 2026” 🌍
ORTHOWORLD put words to a shift that’s already underway: the orthopedic patient population is hashtag#evolving and hashtag#diversifying — but parts of Sports Medicine haven’t fully kept pace ➡️ For decades, many solutions were built around a narrower patient profile, while demand continues to grow across hashtag#pediatric, hashtag#female, and hashtag#older active patients—with very different anatomy and bone quality considerations.
🔷 That’s exactly why ABANZA is building a technology platform designed to help surgeons achieve fixation independent of bone quality. The window is open right now: patient demographics are shifting, expectations for early recovery are rising, and the market is ready for solutions built for today—not yesterday.
✅ With a growing portfolio (including hashtag#WasherCap™ ACL, WasherCap™ hashtag#Mini, and our most recent hashtag#QuadLock™ FDA 510(k) clearance), we’re focused on A New Era in Soft Tissue Fixation—innovations that match where the market—and patients—are going 🏃♀️
Thank you again to ORTHOWORLD for the recognition—and to the surgeons and partners helping push the field forward!
If you’re passionate about advancing sports medicine, this is your team 🤝
hashtag#Orthopedics hashtag#SportsMedicine hashtag#MedTech hashtag#SurgicalInnovation hashtag#SoftTissueFixation hashtag#ACL hashtag#MeniscalRoot hashtag#Biomechanics hashtag#PatientOutcomes hashtag#InnovationInHealthcare
